SEC Form 4 · accession 0001179110-17-011721
USANA HEALTH SCIENCES INC · USNA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James Bramble
Officer — Chief Legal Officer and Sec
Period of report
Aug 21, 2017
Accepted (ET)
Aug 22, 2017 · 11:58 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000896264
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 21, 2017 | M | 18,298 | $28.81 | A | 20,374 | D | |
| Common stockF2 | Aug 21, 2017 | S | 18,298 | $57.0147 | D | 2,076 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Settled Stock Appreciation Rights | $28.81 | Aug 21, 2017 | M | 37,000 | D | Aug 15, 2016 | Mar 15, 2018 | Common Stock | 37,000 | 0 | D |
Explanation of responses
- F1The shares acquired resulted from the reporting person's settlement of the stock-setteld stock appreciation rights disclosed in Table-II
- F2Weighted average price $57.0147. Price range in multiple transactions was $57.00 to $57.30 inclusively.